These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 22351072)

  • 1. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic dysfunction in Parkinson's disease.
    Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
    Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
    Chou JS; Chen CY; Chen YL; Weng YH; Yeh TH; Lu CS; Chang YM; Wang HL
    Neurobiol Dis; 2014 Aug; 68():190-9. PubMed ID: 24830390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2.
    Belluzzi E; Greggio E; Piccoli G
    Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
    Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease.
    Gardoni F; Ghiglieri V; Di Luca M; Calabresi P
    Prog Brain Res; 2010; 183():169-82. PubMed ID: 20696320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
    Durante V; de Iure A; Loffredo V; Vaikath N; De Risi M; Paciotti S; Quiroga-Varela A; Chiasserini D; Mellone M; Mazzocchetti P; Calabrese V; Campanelli F; Mechelli A; Di Filippo M; Ghiglieri V; Picconi B; El-Agnaf OM; De Leonibus E; Gardoni F; Tozzi A; Calabresi P
    Brain; 2019 May; 142(5):1365-1385. PubMed ID: 30927362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease-Linked LRRK2-G2019S Mutation Alters Synaptic Plasticity and Promotes Resilience to Chronic Social Stress in Young Adulthood.
    Matikainen-Ankney BA; Kezunovic N; Menard C; Flanigan ME; Zhong Y; Russo SJ; Benson DL; Huntley GW
    J Neurosci; 2018 Nov; 38(45):9700-9711. PubMed ID: 30249796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
    Beccano-Kelly DA; Volta M; Munsie LN; Paschall SA; Tatarnikov I; Co K; Chou P; Cao LP; Bergeron S; Mitchell E; Han H; Melrose HL; Tapia L; Raymond LA; Farrer MJ; Milnerwood AJ
    Hum Mol Genet; 2015 Mar; 24(5):1336-49. PubMed ID: 25343991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
    Tozzi A; Costa C; Siliquini S; Tantucci M; Picconi B; Kurz A; Gispert S; Auburger G; Calabresi P
    Neurobiol Aging; 2012 Aug; 33(8):1792-9. PubMed ID: 21684039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neostriatal mechanisms in Parkinson's disease.
    Chase TN; Oh JD; Blanchet PJ
    Neurology; 1998 Aug; 51(2 Suppl 2):S30-5. PubMed ID: 9711978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity.
    Zhu G; Chen Y; Huang Y; Li Q; Behnisch T
    Toxicol Appl Pharmacol; 2011 Aug; 254(3):332-41. PubMed ID: 21605582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.
    Calabresi P; Galletti F; Saggese E; Ghiglieri V; Picconi B
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S259-62. PubMed ID: 18267247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD.
    Picconi B; Ghiglieri V; Bagetta V; Barone I; Sgobio C; Calabresi P
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S145-9. PubMed ID: 18583173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice.
    Martella G; Madeo G; Maltese M; Vanni V; Puglisi F; Ferraro E; Schirinzi T; Valente EM; Bonanni L; Shen J; Mandolesi G; Mercuri NB; Bonsi P; Pisani A
    Neurobiol Dis; 2016 Jul; 91():21-36. PubMed ID: 26916954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
    Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
    J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.